Site for Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A multi country non-interventional prospective cohort study among patients with human growth hormone (hGH) treatments under routine clinical care
Brief description of study
Site for This study will explore how safe and effective hGH treatments are in the long term. This study is “non-interventional” because it collects information only.
Clinical Study Identifier: s22-00028
Principal Investigator:
Paul Saenger.
Other Investigator:
Jorge Mejia-Corletto.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.